Zoll Biphasic Defibrillator Study Results Show Superiority In AF Treatment
This article was originally published in The Gray Sheet
Executive Summary
Zoll Medical expects to begin shipping automated and manual versions of its biphasic external defibrillator this summer, backed by results from a company-sponsored clinical study of the device in treating atrial fibrillation.